Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...
The array technology can accommodate a starting genomic DNA samples as small as 25 ng, and Agilent’s CGH Analytics software allows for simultaneous analysis, visualization, and comparison of multiple ...
Modern technologies developed in recent years have prompted new and exciting approaches to support biomedical research. The ability to study the entire human genome using limited sources of genomic ...
Defining regions of genomic imbalance can identify genes involved in tumour development. Conventional cytogenetics has identified several nonrandom copy number alterations (CNA) in uveal melanomas ...
October 19, 2011 (Montreal, Quebec) — Investigators at the University of Pittsburgh have developed a comparative genome hybridization (CGH) microarray that offers significantly superior resolution and ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results